Quick summary
Zinc Thymulin is a metallopeptide of nonapeptide thymulin complexed with zinc, secreted by thymic epithelial cells. Pilot clinical trials report increased anagen hair count and decreased telogen count when applied topically for androgenetic alopecia.
Overview
Zinc Thymulin is a metallopeptide consisting of the nonapeptide thymulin (pyrGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) complexed with a single zinc ion, which is required for its biological activity. Thymulin is naturally secreted by thymic epithelial cells and plays a central role in T-cell differentiation and immune regulation. In hair research, Zinc Thymulin has been studied as a topical intervention for androgenetic alopecia, with evidence suggesting it extends the anagen (growth) phase of the hair cycle and delays follicular miniaturization.
Mechanism of action
Thymulin binds zinc in an equimolar ratio through coordination with serine and asparagine residues, forming the biologically active metallopeptide. In the immune system, Zinc Thymulin induces T-cell differentiation markers and enhances CD4+ and CD8+ subset function via thymulin receptors on lymphoid precursors. In hair follicle biology, Zinc Thymulin promotes anagen phase extension by stimulating keratinocyte proliferation and reducing local inflammatory cytokines (IL-1β, TNF-α) implicated in follicular miniaturization. It may also activate dormant hair follicle stem cells, promoting follicle neogenesis and increasing hair follicle density. Zinc's role is dual: activating the peptide's receptor-binding conformation and providing anti-inflammatory and 5α-reductase-modulating activity locally.
Dosing protocols
| Purpose | Route | Dosage | Frequency | Notes |
|---|---|---|---|---|
| androgenetic alopecia (topical research use) | topical | 0.01–0.05 % | once or twice daily | Used in pilot trials at 0.01–0.05% in topical solution applied to the scalp. Systemic nasal routes have also been explored in research settings. |
Dosing information is for educational purposes only. Consult a qualified healthcare professional before using any peptide.
Research summary
A pilot randomized controlled trial published in the Journal of Drugs in Dermatology analyzed topical Zinc Thymulin in patients with androgenetic alopecia, reporting significant increases in anagen hair count and decreases in telogen count versus placebo after 6 months. A published safety and efficacy analysis in a peer-reviewed journal confirmed tolerability with no systemic absorption detected. Most studies are manufacturer-sponsored and small in scale. No large Phase II/III trials in hair loss have been published as of 2026.[1][2][3][4]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with Zinc Thymulin for synergistic effects.
Legal status
Available as a research peptide and from some compounding pharmacies for topical use. Not FDA-approved for any indication. Some practitioners prescribe compounded formulations off-label for hair loss.
Sourcing & access
Research compound
Zinc Thymulin is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
Zinc Thymulin is a metallopeptide consisting of the nonapeptide thymulin complexed with a zinc ion. Thymulin is naturally secreted by thymic epithelial cells and requires zinc for biological activity. It plays roles in both immune regulation and hair follicle biology.
Zinc Thymulin promotes anagen (growth) phase extension by stimulating keratinocyte proliferation and reducing local inflammatory cytokines (IL-1beta, TNF-alpha) implicated in follicular miniaturization. Zinc also provides anti-inflammatory and 5-alpha-reductase-modulating activity locally.
Topical studies report mild scalp irritation as rare, with no systemic side effects detected. It is available from research peptide suppliers and some compounding pharmacies for topical use but is not FDA-approved for any indication.
A pilot RCT in the Journal of Drugs in Dermatology reported significant increases in anagen hair count and decreases in telogen count versus placebo after 6 months of topical use at 0.01-0.05% concentration. Most studies are manufacturer-sponsored and small scale.
Research references
- Zinc-thymulin complex (FTS-Zn): structure, activation, and T-cell biologyPubMed
- Zinc and thymulin in immunosenescence: age-related thymic involutionPubMed
- Zinc-dependent thymulin as a T-cell maturation hormonePubMed
- Thymulin (serum thymic factor) zinc-dependency: physiological and pharmacological implicationsPubMed